Dr mohammed abdelgawad crbsi
-
Upload
melkholy -
Category
Health & Medicine
-
view
114 -
download
2
Transcript of Dr mohammed abdelgawad crbsi
![Page 1: Dr mohammed abdelgawad crbsi](https://reader034.fdocuments.us/reader034/viewer/2022051404/5a652e5a7f8b9ae13f8b46e9/html5/thumbnails/1.jpg)
Catheter Related Blood Stream Infection (CRBSI)
Diagnosis & Management Step-Wise Practical Approach in HD Patients
Mohammed Abdel GawadNephrology Specialist
Kidney & Urology Center (KUC)
Alexandria – EGY
1st Annual Interventional Nephrology Meeting – ESNTMansoura, 26-27/Oct/2017
![Page 2: Dr mohammed abdelgawad crbsi](https://reader034.fdocuments.us/reader034/viewer/2022051404/5a652e5a7f8b9ae13f8b46e9/html5/thumbnails/2.jpg)
Talk Outline
• Diagnosis
• Management
• Prevention
![Page 3: Dr mohammed abdelgawad crbsi](https://reader034.fdocuments.us/reader034/viewer/2022051404/5a652e5a7f8b9ae13f8b46e9/html5/thumbnails/3.jpg)
Talk Outline
• Diagnosis
• Management
• Prevention
![Page 4: Dr mohammed abdelgawad crbsi](https://reader034.fdocuments.us/reader034/viewer/2022051404/5a652e5a7f8b9ae13f8b46e9/html5/thumbnails/4.jpg)
Paired Blood Cultures
Peripheral vein
From the catheter
Culture of the catheter tip (distal 5 cm)
or
![Page 5: Dr mohammed abdelgawad crbsi](https://reader034.fdocuments.us/reader034/viewer/2022051404/5a652e5a7f8b9ae13f8b46e9/html5/thumbnails/5.jpg)
Paired Blood Cultures
or
When a peripheral blood sample cannot be obtained
From the catheter
From Dialysis circuit
2 quantitative blood cultures of samples obtained through
2 catheter lumens
![Page 6: Dr mohammed abdelgawad crbsi](https://reader034.fdocuments.us/reader034/viewer/2022051404/5a652e5a7f8b9ae13f8b46e9/html5/thumbnails/6.jpg)
Culture Results
Results Diagnosis
Same organism from both samples CRBSI Confirmed
Both negative CRBSI Unlikely
Negative peripheral blood cultureBUT
Positive central blood culture
Probably contamination (don’t treat EXCEPT if
Staph. Aureus)
![Page 7: Dr mohammed abdelgawad crbsi](https://reader034.fdocuments.us/reader034/viewer/2022051404/5a652e5a7f8b9ae13f8b46e9/html5/thumbnails/7.jpg)
Talk Outline
• Diagnosis
• Management
• Prevention
![Page 8: Dr mohammed abdelgawad crbsi](https://reader034.fdocuments.us/reader034/viewer/2022051404/5a652e5a7f8b9ae13f8b46e9/html5/thumbnails/8.jpg)
Talk Outline
• Diagnosis
• Management
• Prevention
![Page 9: Dr mohammed abdelgawad crbsi](https://reader034.fdocuments.us/reader034/viewer/2022051404/5a652e5a7f8b9ae13f8b46e9/html5/thumbnails/9.jpg)
![Page 10: Dr mohammed abdelgawad crbsi](https://reader034.fdocuments.us/reader034/viewer/2022051404/5a652e5a7f8b9ae13f8b46e9/html5/thumbnails/10.jpg)
![Page 11: Dr mohammed abdelgawad crbsi](https://reader034.fdocuments.us/reader034/viewer/2022051404/5a652e5a7f8b9ae13f8b46e9/html5/thumbnails/11.jpg)
Pathway 1: Catheter Salvage
Start Empirical Antibiotics + Antibiotic Lock Therapy
Reassess after 2-3 days: Clinically (fever) & Lab (WBC, CRP)
Improving?
Yes
Continue antibotics, then:
Pathway 3: Surveillance
No
Pathway 4: Catheter removal
Pathway 1: Catheter Salvage
![Page 12: Dr mohammed abdelgawad crbsi](https://reader034.fdocuments.us/reader034/viewer/2022051404/5a652e5a7f8b9ae13f8b46e9/html5/thumbnails/12.jpg)
Empirical Antibiotics Antibiotic To cover Condition
Vancomycin MRSA for institutions in with preponderance of MRSA
Gentamycin(if absolutely
contraindicated use Quinolones)
Gram –ve---------------------
Meropenem, Imipenemor Etrapenem
or Piperacillin/Tazobactamin community with low incidence of antibiotic
resistance
MDR Gram –ve In neutropenic patients, severely ill patients with sepsis, or patients
known to be colonized with such pathogens
Fluconazole or Echinocandin
Candidemia total parenteral nutrition, prolonged use ofbroad-spectrum antibiotics, hematologic
malignancy, receipt of bone marrow or solid-organ transplant, femoral catheterization,or colonization due to Candida species at
multiple sites
![Page 13: Dr mohammed abdelgawad crbsi](https://reader034.fdocuments.us/reader034/viewer/2022051404/5a652e5a7f8b9ae13f8b46e9/html5/thumbnails/13.jpg)
Alternatives to vancomycin as a first choice broad spectrum
Condition Alternative
the preponderance of MRSA isolates have vancomycin
minimum inhibitory concentration (MIC) values 12
mg/mL
Daptomycin
![Page 14: Dr mohammed abdelgawad crbsi](https://reader034.fdocuments.us/reader034/viewer/2022051404/5a652e5a7f8b9ae13f8b46e9/html5/thumbnails/14.jpg)
Antibiotic Doses: VANCOMYCIN
2017
![Page 15: Dr mohammed abdelgawad crbsi](https://reader034.fdocuments.us/reader034/viewer/2022051404/5a652e5a7f8b9ae13f8b46e9/html5/thumbnails/15.jpg)
Antibiotic Doses: GENTAMICIN
2017
![Page 16: Dr mohammed abdelgawad crbsi](https://reader034.fdocuments.us/reader034/viewer/2022051404/5a652e5a7f8b9ae13f8b46e9/html5/thumbnails/16.jpg)
Dialyziability & Residual Renal Function Effect
• Vancomycin is not removed by HD; gentamicin is.
• Measure gent levels daily (levels will decrease sooner in patients with significant residual function).
• Monitor predialysis trough levels if possible
2017
![Page 17: Dr mohammed abdelgawad crbsi](https://reader034.fdocuments.us/reader034/viewer/2022051404/5a652e5a7f8b9ae13f8b46e9/html5/thumbnails/17.jpg)
Antibiotic Doses: MEROPENEM
2017
![Page 18: Dr mohammed abdelgawad crbsi](https://reader034.fdocuments.us/reader034/viewer/2022051404/5a652e5a7f8b9ae13f8b46e9/html5/thumbnails/18.jpg)
Antibiotic Doses: IMIPENEM
2017
![Page 19: Dr mohammed abdelgawad crbsi](https://reader034.fdocuments.us/reader034/viewer/2022051404/5a652e5a7f8b9ae13f8b46e9/html5/thumbnails/19.jpg)
Antibiotic Doses: ERTAPENEM
2017
![Page 20: Dr mohammed abdelgawad crbsi](https://reader034.fdocuments.us/reader034/viewer/2022051404/5a652e5a7f8b9ae13f8b46e9/html5/thumbnails/20.jpg)
Antibiotic Doses: PIPERACILLIN/TAZOBACTAM
2017
![Page 21: Dr mohammed abdelgawad crbsi](https://reader034.fdocuments.us/reader034/viewer/2022051404/5a652e5a7f8b9ae13f8b46e9/html5/thumbnails/21.jpg)
Antifungal Doses: FLUCONAZOL
2017
![Page 22: Dr mohammed abdelgawad crbsi](https://reader034.fdocuments.us/reader034/viewer/2022051404/5a652e5a7f8b9ae13f8b46e9/html5/thumbnails/22.jpg)
Pathway 1: Catheter Salvage
Start Empirical Antibiotics + Antibiotic Lock Therapy
Reassess after 2-3 days: Clinically (fever) & Lab (WBC, CRP)
Improving?
Yes
Continue antibiotics, then:
Pathway 3: Surveillance
No
Pathway 4: Catheter removal
Pathway 1: Catheter Salvage
![Page 23: Dr mohammed abdelgawad crbsi](https://reader034.fdocuments.us/reader034/viewer/2022051404/5a652e5a7f8b9ae13f8b46e9/html5/thumbnails/23.jpg)
![Page 24: Dr mohammed abdelgawad crbsi](https://reader034.fdocuments.us/reader034/viewer/2022051404/5a652e5a7f8b9ae13f8b46e9/html5/thumbnails/24.jpg)
![Page 25: Dr mohammed abdelgawad crbsi](https://reader034.fdocuments.us/reader034/viewer/2022051404/5a652e5a7f8b9ae13f8b46e9/html5/thumbnails/25.jpg)
Pathway 1: Catheter Salvage
Start Empirical Antibiotics + Antibiotic Lock Therapy
Reassess after 2-3 days: Clinically (fever) & Lab (WBC, CRP)
Improving?
Yes
Continue antibiotics, then:
Pathway 3: Surveillance
No
Pathway 4: Catheter removal
Pathway 1: Catheter Salvage
Duration of Systemic and
Antibiotic Lock
![Page 26: Dr mohammed abdelgawad crbsi](https://reader034.fdocuments.us/reader034/viewer/2022051404/5a652e5a7f8b9ae13f8b46e9/html5/thumbnails/26.jpg)
Duration of Systemic and Antibiotic Lock
Pathway 1: Catheter Salvage
If catheter is retained for a patient with S. aureus CRBSI
Continue systemic and antibiotic
lock therapy for 4 weeks
![Page 27: Dr mohammed abdelgawad crbsi](https://reader034.fdocuments.us/reader034/viewer/2022051404/5a652e5a7f8b9ae13f8b46e9/html5/thumbnails/27.jpg)
Duration of Systemic and Antibiotic Lock
Pathway 1: Catheter Salvage
If catheter is retained for a patient with any other organism
No clear data for systemic and antibiotic lock therapy salvage
duration
![Page 28: Dr mohammed abdelgawad crbsi](https://reader034.fdocuments.us/reader034/viewer/2022051404/5a652e5a7f8b9ae13f8b46e9/html5/thumbnails/28.jpg)
Antibiotic Lock Special Situation
Multiple positive catheter blood culture BUT concurrent negative peripheral
blood cultures
Antibiotic lock therapy without systemic therapy for 10–14 days
![Page 29: Dr mohammed abdelgawad crbsi](https://reader034.fdocuments.us/reader034/viewer/2022051404/5a652e5a7f8b9ae13f8b46e9/html5/thumbnails/29.jpg)
![Page 30: Dr mohammed abdelgawad crbsi](https://reader034.fdocuments.us/reader034/viewer/2022051404/5a652e5a7f8b9ae13f8b46e9/html5/thumbnails/30.jpg)
guide wire
Start Empirical Antibiotics as in salvage pathway
Reassess after 2-3 days: Clinically (fever) & Lab (WBC, CRP)
Improving?
Yes
Exchange on guide wire
Continue antibiotics
Pathway 3: Surveillance
No
Pathway 4: Catheter removal
Pathway 2: Exchange on guide wire
Duration of Systemic and
Antibiotic Lock
![Page 31: Dr mohammed abdelgawad crbsi](https://reader034.fdocuments.us/reader034/viewer/2022051404/5a652e5a7f8b9ae13f8b46e9/html5/thumbnails/31.jpg)
Duration of Systemic and Antibiotic Lock
If catheter is exchanged for a patient with any organism
No clear data for systemic and antibiotic lock therapy salvage
duration
Pathway 2: Exchange on guide wire
![Page 32: Dr mohammed abdelgawad crbsi](https://reader034.fdocuments.us/reader034/viewer/2022051404/5a652e5a7f8b9ae13f8b46e9/html5/thumbnails/32.jpg)
![Page 33: Dr mohammed abdelgawad crbsi](https://reader034.fdocuments.us/reader034/viewer/2022051404/5a652e5a7f8b9ae13f8b46e9/html5/thumbnails/33.jpg)
Pathway 3: Surveillance
bloodstream infection that continuesdespite >72 h of antimicrobial therapy
to which the infecting microbes are susceptible
2 sets of blood cultures obtained on a given day
![Page 34: Dr mohammed abdelgawad crbsi](https://reader034.fdocuments.us/reader034/viewer/2022051404/5a652e5a7f8b9ae13f8b46e9/html5/thumbnails/34.jpg)
Pathway 3: Surveillance If the catheter has been retained
Surveillance blood cultures 1 week after completion of an antibiotic course
If blood cultures +ve → the catheter should be removed
New, long term dialysis catheter after additional –ve blood cultures
![Page 35: Dr mohammed abdelgawad crbsi](https://reader034.fdocuments.us/reader034/viewer/2022051404/5a652e5a7f8b9ae13f8b46e9/html5/thumbnails/35.jpg)
![Page 36: Dr mohammed abdelgawad crbsi](https://reader034.fdocuments.us/reader034/viewer/2022051404/5a652e5a7f8b9ae13f8b46e9/html5/thumbnails/36.jpg)
Pathway 4: Catheter removal
Remove catheter and culture tip (5 cm)
Start empirical antibiotics as in salvage pathway
Is access is needed urgently for dialysis?
Yes
Insert temporary catheter in
another site for short
period of time
No
Continue antibiotics
Insert long term catheter ONLY if:
1- afebrile for 48-72 hours
2- CRP is normal
3- Blood cultures are -ve
Duration?
![Page 37: Dr mohammed abdelgawad crbsi](https://reader034.fdocuments.us/reader034/viewer/2022051404/5a652e5a7f8b9ae13f8b46e9/html5/thumbnails/37.jpg)
Pathway 4: Catheter removal
![Page 38: Dr mohammed abdelgawad crbsi](https://reader034.fdocuments.us/reader034/viewer/2022051404/5a652e5a7f8b9ae13f8b46e9/html5/thumbnails/38.jpg)
Persistent fungemia or bacteremia >72 h after catheter
removal
4 to 6 weeks of antibiotic therapy
should be administered
Additional TEE should be obtained
Catheter Removal Special Situation (1)
![Page 39: Dr mohammed abdelgawad crbsi](https://reader034.fdocuments.us/reader034/viewer/2022051404/5a652e5a7f8b9ae13f8b46e9/html5/thumbnails/39.jpg)
Catheter Removal Special Situation (2)
Catheter tip grows S. aureus
but
Initial peripheral blood cultures -ve
5–7-day course of antibiotics
Close monitoring for signs and symptoms of ongoing infection, including additional blood cultures, as indicated
![Page 40: Dr mohammed abdelgawad crbsi](https://reader034.fdocuments.us/reader034/viewer/2022051404/5a652e5a7f8b9ae13f8b46e9/html5/thumbnails/40.jpg)
Talk Outline
• Diagnosis
• Management
• Prevention
![Page 41: Dr mohammed abdelgawad crbsi](https://reader034.fdocuments.us/reader034/viewer/2022051404/5a652e5a7f8b9ae13f8b46e9/html5/thumbnails/41.jpg)
Talk Outline
• Diagnosis
• Management
• Prevention
![Page 42: Dr mohammed abdelgawad crbsi](https://reader034.fdocuments.us/reader034/viewer/2022051404/5a652e5a7f8b9ae13f8b46e9/html5/thumbnails/42.jpg)
Prevention - Catheter
• Strict aseptic circumstances.
• Avoid as much as possible:
– using non-tunneled catheters.
– using femoral
• Monitor the catheter:
– visually when changing the dressing
– or by palpation through an intact dressing on aregular basis.
![Page 43: Dr mohammed abdelgawad crbsi](https://reader034.fdocuments.us/reader034/viewer/2022051404/5a652e5a7f8b9ae13f8b46e9/html5/thumbnails/43.jpg)
Prevention – Exit Site
• Application of antibiotic ointment at the exitsite until the insertion site has healed
• The catheter exit site should be covered by adressing as long as the catheter remains inplace.
![Page 44: Dr mohammed abdelgawad crbsi](https://reader034.fdocuments.us/reader034/viewer/2022051404/5a652e5a7f8b9ae13f8b46e9/html5/thumbnails/44.jpg)
Prevention – Antimicrobial Lock
• Its use is debated.
• Its use may be saved to patients with:– history of multiple CRBSI – those with high risk of severe sequelae (patients
with pacemakers, prosthetic valve or IV devices).
• Citrate locks have, for the time being, most extensively been studied. (The 4% solution seems to offer at present the best benefit/risk ratio).
![Page 45: Dr mohammed abdelgawad crbsi](https://reader034.fdocuments.us/reader034/viewer/2022051404/5a652e5a7f8b9ae13f8b46e9/html5/thumbnails/45.jpg)
Prevention – Staphylococcus
• Eradication of Staphylococcus carriage (nasal mupirocin cream).
• Consider IV antibiotics at insertion for patients with Staphylococcal skin colonisation.
![Page 46: Dr mohammed abdelgawad crbsi](https://reader034.fdocuments.us/reader034/viewer/2022051404/5a652e5a7f8b9ae13f8b46e9/html5/thumbnails/46.jpg)
Always re-evaluate for alternative access
(AVF or AVG).
![Page 47: Dr mohammed abdelgawad crbsi](https://reader034.fdocuments.us/reader034/viewer/2022051404/5a652e5a7f8b9ae13f8b46e9/html5/thumbnails/47.jpg)
References
![Page 48: Dr mohammed abdelgawad crbsi](https://reader034.fdocuments.us/reader034/viewer/2022051404/5a652e5a7f8b9ae13f8b46e9/html5/thumbnails/48.jpg)
References
![Page 49: Dr mohammed abdelgawad crbsi](https://reader034.fdocuments.us/reader034/viewer/2022051404/5a652e5a7f8b9ae13f8b46e9/html5/thumbnails/49.jpg)
Thank You